Skip to content

Medical emergency? What to do

MS drug may raise risk of miscarriage

3-RXPublished October 5, 20052 min read

Key points

  • Pregnant women being treated with beta-interferon, a drug used to fight multiple sclerosis and other diseases, face an increased risk of miscarriage or having a low birthweight baby, according to two new reports.
  • In the interferon group, 55 percent of the pregnancies resulted in live births, compared with 90 percent in the healthy comparison group.
  • Offspring in the group exposed to interferon also weighed approximately 200 grams less at birth than those born to healthy mothers, the investigators report in the medical journal Neurology.
  • Magnhild Sandberg-Wollheim from University Hospital in Lund, Sweden, and colleagues reviewed pregnancy outcomes of women enrolled in eight clinical trials of beta-interferon for treatment of multiple sclerosis.

Pregnant women being treated with beta-interferon, a drug used to fight multiple sclerosis and other diseases, face an increased risk of miscarriage or having a low birthweight baby, according to two new reports.

Dr. Gideon Koren, from The Hospital for Sick Children in Toronto, and his colleagues studied interferon's reproductive effects in 16 women with 23 pregnancies exposed to beta-interferon, comparing them with 18 similar but unaffected women with 20 pregnancies.

In the interferon group, 55 percent of the pregnancies resulted in live births, compared with 90 percent in the healthy comparison group.

Another 12 women with 21 pregnancies had discontinued interferon treatment at least 1 month prior to conception, and the live birth rate in this group was 81 percent.

Offspring in the group exposed to interferon also weighed approximately 200 grams less at birth than those born to healthy mothers, the investigators report in the medical journal Neurology.

"Women who become pregnant while taking beta interferon should not terminate pregnancy but rather discontinue the drug until delivery," Koren's team advises.

In a second report, by Dr. Magnhild Sandberg-Wollheim from University Hospital in Lund, Sweden, and colleagues reviewed pregnancy outcomes of women enrolled in eight clinical trials of beta-interferon for treatment of multiple sclerosis.

A total of 69 pregnancies were reported. Forty-one occurred in women who were receiving the drug at the time of conception or had discontinued it within 2 weeks prior to conception (the "in utero" exposure group). Twenty-two occurred in patients who had discontinued treatment more than 2 weeks prior to conception (the "prior exposure" group).

In the in utero group, the spontaneous pregnancy loss rate was 29 percent, but the authors note that this rate is not significantly different from that predicted in the general population.

In the prior exposure group, there were 20 full-term healthy infants, one healthy premature infant, and one birth-related congenital defect.

The researchers conclude that "patients should still be advised to discontinue beta interferon-1a prior to planned pregnancy or if they become pregnant."

In an accompanying editorial, two experts comment that "discontinuation of beta-interferon ... (and any disease-modifying therapy) prior to initiating pregnancy should remain the rule whenever possible."

SOURCE: Neurology, September 27, 2005.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underPregnancy

Keep reading

Genetics

Genes in mother, baby raise risk of preterm birth

Genes in the mother and the fetus play a role in the risk of preterm labor, a leading cause of infant death and disability, U.S. government researchers said on Thursday. They said gene variants in the mother and…

3 min read

Pregnancy

Postpartum Baby Blues Impact Majority of New Moms

Tracy Perkins Rodriguez, 36, thought her life was finally on the upswing. When her husband returned from his third tour of duty in Iraq and Afghanistan, the couple purchased their dream home and promptly became…

4 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.